Temasek Holdings

Temasek Holdings is a Singapore-based investment company founded in 1974. The firm specializes in providing debt financing and is dedicated to transforming economies, enhancing middle-income populations, and fostering emerging champions. Temasek operates across various sectors, including financial services, transportation, industrial, consumer goods, real estate, telecommunications, media, technology, and life sciences. Its strategic focus is on developing comparative advantages within these industries to support sustainable growth and innovation.

Pradyumna Agrawal

Director

Soyoun Ahn

Managing Director, Investment (Credit and Hybrid Solutions)

Gary Ang

Managing Director, Macro Strategy

Parimal Aswani

Managing Director, Technology

Ravi Balasubramanian

Managing Director, Portfolio Development, New Energy and Industrials

Siddartha Bhattacharjee

Head of Mobility and Logistics and Managing Director of Portfolio Strategy & Risk Group

Dawn Chan

Director of Investments

Yuliang Chang

Managing Director, Investment (China)

Eu Chua

Managing Director, Institutional Relations and Singapore Market

Ranjit Dandekar

Managing Director, Investment

Nagi Hamiyeh

Senior Managing Director

Reena Kanagasingam

Managing Director, Investment (Public Markets)

Ming Pey Lim

Chief of Staff, Executive Office, Deputy Chief Corporate Officer and Managing Director, Strategy Office

Paul Liu

Managing Director, Investment (Financial Services), Portfolio Strategy and Risk Group

Anuj Maheshwari

Head, Agri-Food Managing Director, Investment (Middle East and Africa)

Nicolas Meier

Managing Director, Investment (EMEA) and Director

Jingwen Miao

Managing Director, Investment (China)

Suranjan Mukherjee

Managing Director, Cross Asset Macro Portfolio and Joint Head, Public Market Investment Strategies

Ryan Rakestraw

Director

Parangam Ray

Managing Director, Organisation and People

Pierce Scranton

Managing Director, Institutional Relations and Deputy Head, North America

Shaun Seow

Managing Director, Singapore Market and Head, Community Stewardship

Jason Sun

Chief Representative, Beijing and Managing Director, Investment (China)

Belinda Tan

Managing Director, Finance (Financial Management)

Man-Keung Tang

Managing Director, Macro Strategy

Sulian Tay

Operating Partner

Karen Toh

Managing Director, Finance (Treasury)

Damien Vacherot

Director

Benoit Valentin

Senior Managing Director EMEA and Head of Private Equity Fund Investments

Rob Williams

Managing Director, Investment (EMEA)

Yibing Wu Ph.D

CEO, China

Past deals in Series B

Electra

Series B in 2025
Electra is dedicated to reducing carbon dioxide emissions in the iron and steel production industry through innovative electrochemical and hydrometallurgical processes. The company has developed alternative steelmaking technology that aims to electrify and decarbonize the production process, allowing for the creation of low-carbon clean iron from various ores. By utilizing renewable energy sources, Electra enables steel producers to lower energy intensity and costs, contributing to a more sustainable approach to steelmaking.

FAIRMAT

Series B in 2025
We are bringing new, sustainable and innovative way to recycle carbon fiber composite. Thanks to our proprietary technology, we produce a recycled material. It's a light and strong high-tech material designed to be used in industries such as mobility, consumer electronics, automotive, and sports & leisure.

Aira

Series B in 2024
Aira operates as a clean energy-tech company that provides heat pumps and home energy-saving solutions. Aira aims to lower CO2 emissions from residential heating, reduce reliance on foreign gas, and decrease consumer energy bills. Aira speeds up the electrification of residential heating with smart clean energy technology, paving the way for the net zero future that consumers need.

Partior

Series B in 2024
Partior is a developer of a blockchain platform focused on enhancing cross-border payments and settlements for financial institutions. By utilizing blockchain and distributed ledger technology, Partior aims to streamline digital payments, making them more efficient, reliable, and secure. The platform facilitates real-time, multi-currency transactions, which increases transparency and accelerates the payment process. It addresses common challenges in cross-border payments, such as manual reconciliation and the need for pre-funding of nostro accounts, thereby helping financial institutions unlock capital and improve operational efficiency. Through its innovative approach, Partior provides digital clearing and settlement services that reduce friction in trade and foreign exchange settlements.

Antora Energy

Series B in 2024
Antora Energy specializes in providing zero-carbon industrial heat and power solutions for heavy industries, offering a more reliable alternative to fossil fuels. The company develops innovative thermal batteries that utilize excess solar and wind electricity to heat blocks of carbon, creating a sustainable energy source. These thermal energy storage systems effectively convert heat energy into electric energy, facilitating the electrification of heavy industry. By enabling the integration of renewable resources into the electricity grid, Antora Energy aims to deliver convenient, sustainable, and reliable electricity while significantly reducing carbon emissions on a global scale.

Aira

Series B in 2024
Aira operates as a clean energy-tech company that provides heat pumps and home energy-saving solutions. Aira aims to lower CO2 emissions from residential heating, reduce reliance on foreign gas, and decrease consumer energy bills. Aira speeds up the electrification of residential heating with smart clean energy technology, paving the way for the net zero future that consumers need.

Robin AI

Series B in 2024
Robin AI is a legal technology startup focused on automating legal processes through artificial intelligence. Its software enhances the contract mark-up process by providing essential features while ensuring enterprise-grade encryption and security, which helps safeguard sensitive data. The platform empowers legal teams to delegate low-complexity tasks, thereby simplifying and streamlining legal workflows. By automating routine aspects of legal work, Robin AI enables professionals to concentrate on more complex and high-value tasks, ultimately improving productivity and efficiency within legal practices.

Eavor

Series B in 2023
Eavor Technologies Inc., established in 2017 and headquartered in Calgary, Canada, specializes in generating industrial-scale electricity using innovative geothermal technology. The company's core product, the Eavor-Loop™ system, harnesses heat from deep within the earth, utilizing wells to produce brine from a subsurface aquifer. This heat is then employed for commercial heating applications. Eavor also operates the Eavor-Lite™ Demonstration Project, a prototype of its technology suite. The company's solution aims to provide a clean, carbon-neutral, and scalable baseload power source, mitigating traditional geothermal challenges by using existing commercial componentry in a novel configuration and leveraging recent advances in drilling techniques and heat-to-power generation technology.

d-Matrix

Series B in 2023
D-Matrix is a technology company focused on developing a computing platform aimed at enhancing artificial intelligence inferencing workloads in data centers. The company is dedicated to creating an innovative, brain-inspired AI compute engine that addresses a wide range of inferencing tasks within the growing cloud and edge infrastructure markets. By employing an in-memory computing approach, D-Matrix seeks to improve the efficiency of memory-compute integration through advanced mixed-signal and digital signal processing techniques. This platform is particularly designed to support generative artificial intelligence applications and large language models, thereby providing clients with enhanced computational capabilities.

Verdagy

Series B in 2023
Verdagy is focused on advancing water electrolysis technology to enable large-scale production of green hydrogen. Based in Moss Landing, California, the company develops high-performance cells, electrolyzers, and plants aimed at achieving low upfront capital and operating costs. Their innovative approach positions them to offer competitive unit economics in hydrogen production, making it more accessible for various industries to adopt clean energy solutions. Verdagy operates laboratory and pilot plant facilities to support the rapid scaling of its technology platform.

Amogy

Series B in 2023
Amogy is a company dedicated to creating carbon-free energy solutions for hard-to-abate sectors such as maritime, power generation, and heavy industry. The company's patented ammonia cracking technology effectively splits liquid ammonia to produce electrical power in combination with hydrogen fuel cells. This innovative approach not only enhances energy density but also offers a renewable fuel source that operates with zero carbon emissions, making it a cost-effective option for the transportation industry. By focusing on these advanced technologies, Amogy aims to facilitate emission-free mobility applications, contributing to the broader goal of decarbonization in various industries.

Ionblox

Series B in 2023
Ionblox specializes in advanced battery technology that focuses on the development of silicon-based formulations to enhance lithium-ion batteries. The company has created proprietary anodes characterized by high active silicon content and loading levels, which address common issues such as poor cycling performance and swelling. By integrating these high-capacity anodes with innovative cathode materials, Ionblox produces large format pouch cells that achieve significantly higher energy densities compared to existing commercial options. This technology is particularly beneficial for electric vehicle manufacturers seeking long-lasting, high-performance batteries.

Our Next Energy

Series B in 2023
Our Next Energy is a Michigan-based company founded in 2020 that specializes in developing energy storage technology aimed at enhancing access to sustainable power. The company focuses on safer battery chemistries utilizing sustainable raw materials, while ensuring a reliable, low-cost, and conflict-free supply chain. It aims to improve energy density and safety in battery technology, catering to mobility and grid storage applications. By employing a dual-chemistry design, Our Next Energy provides innovative power solutions that enable original equipment manufacturers to meet market range expectations effectively.

PASQAL

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

GCL Optoelectronics

Series B in 2022
GCL Optoelectronics is a supplier of perovskite solar modules, focusing on the R&D and production of perovskite solar modules. The company's objective is to supply solar panels that can achieve grid parity for photovoltaic power. They established a comprehensive learning path that includes a path for employees' professional progression.

Agriconomie

Series B in 2022
Agriconomie is an agtech e-commerce company founded in 2014 by Clément Le Fournis, Paolin Pascot, and Dinh Nguyen. It operates an agricultural marketplace designed to facilitate cost-effective purchasing for farmers. The platform offers a diverse selection of products, including fertilizers, seeds, spare parts, workshop equipment, pesticides, and animal nutrition. In addition to providing a comprehensive range of agricultural inputs, Agriconomie supports farmers with purchasing assistance, personalized advice, and access to shared information sources. For input suppliers, the company provides data services, advertising, and software through its Supplier Services division, enhancing the overall efficiency of the agricultural supply chain.

Electra

Venture Round in 2022
Electra is dedicated to reducing carbon dioxide emissions in the iron and steel production industry through innovative electrochemical and hydrometallurgical processes. The company has developed alternative steelmaking technology that aims to electrify and decarbonize the production process, allowing for the creation of low-carbon clean iron from various ores. By utilizing renewable energy sources, Electra enables steel producers to lower energy intensity and costs, contributing to a more sustainable approach to steelmaking.

Well-Link Tech

Series B in 2022
Well-Link is a cloud rendering solutions provider with headquarters in Singapore.

DotPe

Series B in 2022
DotPe is a technology startup based in Gurgaon, Haryana, India, founded in 2019 by Anurag Gupta, Gyanesh Sharma, and Shailaz Nag. The company operates a commerce and payments platform designed to enhance customer engagement and streamline the payment experience for offline enterprises. By providing tools for catalog discovery, customer management, order management, website management, and logistics, DotPe empowers businesses to transition to digital sales effectively. Its solutions aim to help offline businesses increase their sales, improve operational efficiency, and foster direct interactions with customers, thereby facilitating their digital transformation in an increasingly competitive marketplace.

Sironax

Series B in 2022
Sironax is a clinical-stage biotechnology company based in Beijing, China, founded in 2017. The company focuses on developing innovative products and treatments for age-related degenerative diseases, concentrating on mechanisms such as regulated cell death, neuroprotective pathways, and neuroinflammation. By researching apoptosis and other cell death pathways, Sironax aims to create advanced pharmaceuticals that can improve the lives of patients suffering from these conditions. Their goal is to transform the treatment landscape for age-related degenerative diseases, benefiting millions of patients and their families globally.

Circ

Series B in 2022
Circ is a textile recycling company based in Danville, Virginia, focused on recovering value from discarded clothing and textiles. Established in 2011, Circ employs proprietary technology to transform polycotton waste back into its original raw materials, including petroleum- and plant-based fabrics. The company aims to meet growing consumer demands for sustainability without sacrificing quality, price, or convenience. By using water as a solvent, Circ efficiently recycles various fibers, such as cotton, polyester, and nylon, and produces virgin-equivalent, market-grade dissolving pulp and petroleum monomers. These materials can be sold to manufacturers at competitive prices, promoting a circular economy in the textile industry and supporting sustainable living practices.

OnPoint

Series B in 2022
OnPoint is a management consulting firm based in Arlington, Virginia, specializing in delivering secure IT infrastructure and enterprise systems for the U.S. federal government. The company offers a range of technology and management consulting services, including risk management, compliance, strategic integration, security awareness training, and program management. By providing comprehensive solutions, OnPoint helps its clients effectively navigate complex challenges, from marketing and strategic communications to cybersecurity, ensuring that they receive tailored and dynamic support to meet their needs.

Jaguar Microsystems

Series B in 2022
Jaguar Microsystems is a technology company founded by Dr. Sunny Siu in 2020, specializing in cloud computing and data processing solutions for data centers. The company develops data processing unit (DPU) chips that enhance the efficiency of data processing, with a particular emphasis on accelerated Remote Direct Memory Access (RDMA) and RoCE technologies. Jaguar Microsystems targets domestic cloud service providers, telecommunications, and Internet service providers, while also expanding its offerings to meet the demands of the global market.

MojiaBio

Series B in 2022
MojiaBio is a producer of biomanufacturing innovations that aim to improve sustainability. The company, which is dedicated to removing hazardous pollution and excessive energy consumption manufacturing, creates enzyme engineering and biological metabolic pathway engineering platforms to optimize traditional chemical and petroleum production processes.

TeraWatt Technology

Series B in 2022
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, specializes in the design and development of lithium-ion rechargeable batteries for various electrified applications. The company focuses on producing batteries that combine energy and power density with safety, catering to the needs of industrial clients. Through advanced engineering practices and efficient production processes, TeraWatt Technology aims to provide long-lasting, safe, and reliable power alternatives, supporting a wide range of electrification initiatives. Additionally, TeraWatt has a subsidiary located in Tokyo, Japan, further expanding its reach in the global market.

Brightseed

Series B in 2022
Brightseed, Inc. is a biotechnology company based in San Francisco, California, that specializes in the discovery of bioactive compounds in plants to enhance human health. Utilizing its advanced Forager platform, which employs artificial intelligence and machine learning algorithms, Brightseed accelerates the identification and validation of clinically beneficial molecules. This innovative approach enables the company to uncover connections between natural compounds and health outcomes, revealing the potential of bioactives that have previously remained uncharted. By integrating these discoveries back into the food supply chain, Brightseed collaborates with various companies across the consumer health continuum to develop science-backed health solutions aimed at managing chronic diseases and improving overall quality of life. Founded in 2017, Brightseed is committed to exploring the untapped resources of the plant kingdom to address pressing health challenges.

Waresix

Series B in 2022
Waresix is a logistics platform based in Jakarta, Indonesia, that specializes in freight forwarding, warehousing, and land transportation. The platform facilitates the connection between business owners and professional warehouse operators, allowing users to access on-demand warehouse services. Waresix addresses the growing demand for flexible warehousing solutions, particularly in the expanding e-commerce market. By matching unused warehouse space with businesses in need, the platform enables clients—including retailers, distributors, and manufacturers—to effectively manage inventory, adapt to variable demand, and streamline operations through features such as documentation management and billing.

Wildtype

Series B in 2022
Wildtype is an agtech company based in San Francisco that focuses on creating clean and sustainable seafood through cellular agriculture technologies. The company aims to produce sushi-grade salmon that offers the same nutritional benefits as wild-caught fish while eliminating common contaminants such as mercury, microplastics, antibiotics, and pesticides. By developing alternative sources of seafood, Wildtype seeks to address critical global challenges, including climate change, food security, and health, while also protecting wild species and ocean ecosystems. The company's innovative approach provides consumers with a healthier option for seafood, contributing to a more sustainable food system.

Amber Group

Series B in 2022
Amber Group Limited is a cryptocurrency financial services provider based in Hong Kong, founded in 2015. The company specializes in facilitating the buying and selling of cryptocurrency products and offers a range of services, including yield enhancement, collateralized lending, decentralized finance, execution services, and electronic market making. With a global presence that includes operations in Taipei, Seoul, and Vancouver, Amber Group serves over 200 institutional clients and has traded more than $200 billion across multiple electronic exchanges. It aims to optimize investment flexibility and maximize returns for its clients by leveraging advanced technology and quantitative research. Amber Group is dedicated to delivering a streamlined cryptocurrency finance experience, helping clients build and protect their wealth over the long term.

Soul Machines

Series B in 2022
Soul Machines Limited, founded in 2016 and headquartered in Auckland, New Zealand, specializes in the development of emotionally responsive avatars that enhance user experiences across various artificial intelligence platforms. The company offers a range of products, including the Digital DNA Studio, which allows users to create custom digital avatars for applications in customer care, marketing, education, and more. By utilizing its innovative Biological AI technology and patented Digital Brain™, Soul Machines aims to humanize AI, creating engaging and empathetic AI assistants that facilitate deeper interactions and personalized experiences. With additional offices in major cities worldwide, including San Francisco, New York, London, Tokyo, and Melbourne, Soul Machines is at the forefront of transforming customer engagement through ethical and responsive human-machine collaboration.

Waterdrop

Series B in 2022
Waterdrop is a hydration brand based in Vienna, Austria, focused on promoting wellness and sustainable drinking habits. The company offers an innovative product known as the Microdrink, which consists of sugar-free, flavored cubes that dissolve in water, enriching it with natural fruit and plant extracts, as well as essential vitamins. This approach not only enhances hydration but also significantly reduces plastic waste and CO2 emissions. Each cube comes in individual recyclable packaging, and Waterdrop has partnered with Plastic Bank to collect one plastic bottle for every 12-pack sold. With a customer base exceeding 2 million and a workforce of over 300 employees, Waterdrop has established a strong retail presence, featuring its products in more than 20,000 outlets and operating over 40 stores worldwide.

H2Pro

Series B in 2022
H2Pro, Ltd. is a renewable energy company based in Caesarea, Israel, founded in 2019. The company specializes in developing innovative water-splitting technology aimed at producing hydrogen fuel efficiently. Its proprietary method, known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting), effectively decouples the hydrogen and oxygen evolution reactions, allowing for the generation of hydrogen and oxygen in separate phases. This technology is designed to facilitate the widespread adoption of sustainable hydrogen fuel by providing an efficient, affordable, safe, and environmentally friendly means of hydrogen production.

WeNext Technology

Series B in 2021
Wenext, founded in 2014, specializes in online manufacturing services tailored for makers and small to mid-size enterprises (SMEs). The company has produced over 15 million high-quality parts through its efficient digital production facilities. By offering a flexible supply chain with transparent pricing and 24-hour delivery, Wenext enhances production capacity for its clients. The platform facilitates full self-service production, significantly reducing operational costs and production time, with some orders completed in as little as one day. Wenext is ISO 9001 certified, underscoring its commitment to quality in manufacturing processes.

Commonwealth Fusion Systems

Series B in 2021
Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.

RWDC Industries

Series B in 2021
RWDC Industries Ltd is a Singapore-based company that specializes in the development and manufacturing of medium chain length polyhydroxyalkanoate (mcl-PHA) biopolymers. Founded in 2015, the company focuses on creating biodegradable bioplastics that can serve as alternatives to single-use plastics in various applications, including cutlery, drinking straws, cup lids, and food packaging. RWDC's mcl-PHA is produced through the bacterial fermentation of plant-based oils or sugars and is certified to be fully biodegradable in soil, water, and marine environments. The company's innovations, such as a water-based PHA emulsion coating, aim to replace polyethylene in plastic-lined food packaging and offer direct replacements for petroleum-based products like polypropylene straws and polystyrene containers, thus supporting sustainability efforts across industries.

SaladStop!

Series B in 2021
SaladStop! is a leading player in the healthy food movement in Singapore, focusing on making nutritious food convenient and accessible. The restaurant chain specializes in salads, grain bowls, wraps, and smoothies that are made without artificial flavors or coloring, ensuring nutritional transparency for consumers. With 23 outlets currently operating in Singapore and Manila, SaladStop! is on track to expand further into Indonesia and Japan, aligning with its vision of becoming a prominent global name in nutrition, health, and wellness. The company is dedicated to providing delicious and climate-positive food choices, catering to the growing demand for healthier eating options.

Arbor Biotechnologies

Series B in 2021
Arbor Biotechnologies, Inc., founded in 2016 and headquartered in Cambridge, Massachusetts, operates as a bio-discovery company in the biotechnology sector. The company focuses on developing genomic tools that enhance human health and sustainability. Utilizing a combination of artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, Arbor's platform accelerates the discovery of proteins and facilitates human diagnostic development. The technology aggregates genomic sequence data through AI and machine learning, enabling drug developers to replace entire genes and precisely correct mutations. This approach aims to streamline the development of curative treatments for previously incurable genetic diseases, ultimately improving the lives of patients affected by such conditions.

FTX

Series B in 2021
FTX is a cryptocurrency exchange company that specializes in developing a professional trading platform, supporting features such as quarterly and perpetual futures, leveraged tokens, and OTC trading. It aims to cater to both professional trading firms and first-time users, offering an intuitive and robust trading environment. FTX was incubated by Alameda Research, ensuring it had industry order books from its inception. Additionally, FTX Ventures, its investment arm, provides equity and/or token investments to blockchain companies at various stages, supporting founders and maintaining their decision-making flexibility.

Vision X

Series B in 2021
Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

Whale

Series B in 2021
Whale provides an omnichannel marketing platform that transforms marketing operations, digitalizes store operations and unifies offline & online brand experiences leveraging AI + IoT + Big Data to “Connect Brands with Customer”. Founded in 2017, Whale has since empowered 1000+ global FMCG, F&B, Fashion and Automotive brands including P&G, Unilever, Starbucks, UNIQLO, ARMANI, Watsons, Xiaomi, Midea, Lotus, POP MART etc. with over 150,000 stores across APAC, enabling brands to embrace the full potential of digital transformation. Equipped with AI capabilities, patented ReID technology and enterprise-grade security, Whale platforms comprising of Space Data Platform (SDP), Whale Marketing Cloud (WMC), Whale Open Platform (WOP) and Whale Analytics, serve as the end-to-end digitalization engine that enables brands to seamlessly engage with each customer. Whale is backed by Temasek Holding, NIO Capital, Source Code Capital, Linear Capital, Alpha Commune, BAI Capital and The Jiangmen, with 6 offices across Singapore, Hangzhou, Shanghai, Beijing and Shenzhen.

Innovusion

Series B in 2021
Innovusion, Inc. is a developer of advanced image grade LiDAR sensor systems tailored for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, the company focuses on delivering high-performance perception solutions that combine range, resolution, and hardware-accelerated sensor fusion. Their compact sensor systems are designed for ease of integration and cost-effectiveness, making them suitable for demanding applications in the autonomous driving market. Innovusion's innovative technology positions it as a key player in the rapidly evolving landscape of autonomous transportation.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

FTX

Series B in 2021
FTX is a cryptocurrency exchange company that specializes in developing a professional trading platform, supporting features such as quarterly and perpetual futures, leveraged tokens, and OTC trading. It aims to cater to both professional trading firms and first-time users, offering an intuitive and robust trading environment. FTX was incubated by Alameda Research, ensuring it had industry order books from its inception. Additionally, FTX Ventures, its investment arm, provides equity and/or token investments to blockchain companies at various stages, supporting founders and maintaining their decision-making flexibility.

Fortera

Series B in 2021
Fortera is focused on developing innovative cement products that significantly reduce carbon dioxide emissions associated with concrete production. The company has created a process that captures industrial carbon emissions and mineralizes them to produce a less carbon-intensive form of concrete. This method not only aims to lower the environmental impact of construction but also enhances the performance characteristics of their products compared to traditional concrete. By providing a more sustainable alternative, Fortera contributes to the global effort to mitigate greenhouse gas emissions, addressing a critical challenge in the construction industry.

Waymo

Private Equity Round in 2021
Waymo is a self-driving technology company focused on enhancing mobility by creating safe and efficient transportation solutions. Established from advancements in Google's research since 2009, Waymo aims to improve the movement of people and goods through its innovative software and sensor technology. In 2015, the company marked a significant milestone by conducting the world's first fully autonomous trip on public roads in a vehicle devoid of traditional driving controls. Waymo continually refines its technology through extensive simulation testing, accumulating over one billion miles of virtual testing annually, while its autonomous vehicles have logged more than two million miles on public roads in four U.S. cities. By employing integrated sensors and artificial intelligence, Waymo's technology is designed to detect various obstacles such as pedestrians, cyclists, and road conditions, ensuring a safe and convenient on-demand travel experience for users.

Umoja Biopharma

Series B in 2021
Umoja Biopharma specializes in innovative immunotherapy aimed at transforming cancer treatment and enhancing patient quality of life. The company focuses on reprogramming T cells within the patient's body to effectively target cancer, including solid tumors and hematological cancers that often have poor responses to conventional therapies. Its proprietary CAR T-cell gene therapy platform is designed to deliver scalable therapeutic regimens tailored to various stages of cancer, enabling medical practitioners to directly and safely attack cancer cells. By harnessing the body's immune response, Umoja Biopharma seeks to improve overall patient outcomes and provide more effective treatment options for those affected by cancer.

Einride

Series B in 2021
Einride AB, established in 2016, specializes in sustainable freight transportation. Headquartered in Stockholm, Sweden, with additional offices in Gothenburg and Palo Alto, the company manufactures electric trucks, known as Einride Pods, for road freight transportation of various goods. Einride also offers digital platforms for clients to plan, order, and track these sustainable transport services. Notably, Einride became the first company to operate an autonomous, electric freight vehicle on a public road in 2019.

Innovusion

Series B in 2021
Innovusion, Inc. is a developer of advanced image grade LiDAR sensor systems tailored for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, the company focuses on delivering high-performance perception solutions that combine range, resolution, and hardware-accelerated sensor fusion. Their compact sensor systems are designed for ease of integration and cost-effectiveness, making them suitable for demanding applications in the autonomous driving market. Innovusion's innovative technology positions it as a key player in the rapidly evolving landscape of autonomous transportation.

Manner

Series B in 2021
Manner is a specialty coffee chain that believes that coffee should be a healthy drink affordable to all people. While insisting on bringing good coffee to every customer, MANNER also takes environmental protection as its own social responsibility. MANNER will reduce 5 yuan for every behavior of bringing non-disposable paper cups to the store to enjoy coffee. The company is headquartered in Shanghai, China.

Pairwise Plants

Series B in 2021
Pairwise Plants is an agricultural gene editing company based in San Diego, California, focused on enhancing crops such as corn, soybeans, wheat, cotton, and canola. Founded in 2017 by a team of experts in food technology and genetics, Pairwise aims to improve the quality and nutritional value of fruits and vegetables, including leafy greens, berries, and stone fruits. The company collaborates with food and agriculture organizations to provide innovative solutions for both row and specialty crops. Pairwise holds licenses for advanced gene editing technologies from prestigious institutions, enabling the development of new crop varieties. With a commitment to building a healthier world through better food, Pairwise anticipates launching its first products in the coming years.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Locanabio

Series B in 2020
Locanabio, Inc. is a biotechnology company based in San Diego, California, founded in 2016. It specializes in developing RNA-targeted gene therapies aimed at treating a range of underserved diseases, particularly in the areas of neuromuscular, neurodegenerative, and retinal conditions. The company's innovative platform focuses on modifying disease-causing RNA, allowing for the identification and correction of specific RNA sequences associated with rare genetic disorders. This approach distinguishes Locanabio's therapies from traditional DNA-targeted methods, offering a unique solution for patients with severe and challenging health issues. The company, which rebranded from Locana, Inc. in July 2020, is dedicated to advancing therapeutic candidates that address significant medical needs.

v2food

Series B in 2020
V2food is a plant-based meat startup founded in 2019 by Nick Hazell and located in Sydney, New South Wales, Australia. The company specializes in producing legume-based meat alternatives that provide a nutritious and flavorful option for individuals who enjoy the taste of meat but prefer not to consume animal products. V2food's offerings are designed to be sustainable and eco-friendly, utilizing natural ingredients that deliver essential protein, energy, fiber, and specific amino acids. By focusing on reducing greenhouse gas emissions, land degradation, and biodiversity loss, V2food aims to foster a positive relationship with food while contributing to a more sustainable food system.

NUVIA

Series B in 2020
Nuvia, Inc. is a semiconductor company based in Santa Clara, California, founded in 2019. The company specializes in designing and manufacturing silicon chips and microprocessors, specifically focusing on server system-on-chip processors tailored for data centers. Nuvia's processors aim to enhance computing performance while improving power efficiency and security, addressing the evolving demands of compute-intensive applications. By developing advanced processing chipsets, Nuvia seeks to deliver substantial performance and energy efficiency improvements, positioning itself as a key player in the next generation of computing technology.

Lu Daopei Medical Group

Series B in 2020
Lu Daopei Medical Group is a prominent healthcare provider based in Beijing, China, specializing in hematology and bone marrow transplantation. Founded in 2002, the group operates a network of hospitals that offer a range of services, including departments focused on bone marrow transplantation, general hematology, lymphoma and myeloma treatment, as well as pathology and specialty hematology laboratories. The organization is recognized for its expertise in stem cell transplantation and oncology, providing comprehensive clinical diagnosis and treatment options. Lu Daopei Medical Group aims to assist patients in navigating the complexities of their medical care, ultimately reducing their anxiety and improving treatment outcomes.

Glympse Bio

Series B in 2020
Glympse Bio, Inc. is a diagnostic company based in Cambridge, Massachusetts, that focuses on developing modular nanoparticle sensors for noninvasive disease monitoring. Founded in 2015, the company creates engineered diagnostic agents designed to interrogate the body for specific disease states, subsequently conveying this information through urine analysis. This innovative approach facilitates the monitoring of various conditions, including fibrosis, cancer, immunology, and infectious diseases, while also assessing drug responses. Glympse Bio's flagship product, Glympse Inside, serves as a pan-disease platform aimed at revolutionizing how diseases are monitored and treated. The technology was initially developed at MIT and is supported by a team of experts in nanomedicine and biomedical engineering.

JW Therapeutics

Series B in 2020
JW Therapeutics (Shanghai) Co., Ltd. is a biotechnology company based in Shanghai, China, specializing in the development, transformation, and promotion of cell-based immunotherapies. The company focuses on innovative therapies that utilize chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to enhance the body's immune response against cancer. JW Therapeutics is dedicated to creating transformative treatments for both hematological cancers and solid tumors, with its lead product candidate being relmacabtagene autoleucel, a CAR-T therapy targeting anti-CD19. By advancing these groundbreaking therapies, JW Therapeutics aims to improve survival rates and quality of life for cancer patients.

Tropic Biosciences

Series B in 2020
Tropic Biosciences UK Ltd, established in 2016 and based in Norwich, is a biotechnology company specializing in the development of commercial tropical crops. It employs advanced plant breeding and non-GMO gene editing techniques to create high-performing varieties, catering primarily to the coffee and banana industries. The company's mission is to promote grower wellbeing, consumer health, and sustainable environmental practices through its innovative, non-GMO methods, which significantly accelerate the breeding process to meet growing food demands and local community needs.

Genor BioPharma

Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, founded in 2007. It specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing primarily on oncology, autoimmune diseases, and metabolic disorders. The company aims to address significant unmet medical needs through its pipeline, which includes more than ten products, with several already in clinical development. Notable candidates include GB491, an oral CDK4/6 inhibitor; GB221, a novel HER2 mAb; geptanolimab (GB226); and GB242, an infliximab biosimilar. Genor BioPharma also collaborates strategically with Ascentage Pharma to enhance its research and development efforts.

Ascus Biosciences

Series B in 2020
Ascus Biosciences, founded in 2015 and headquartered in San Diego, California, focuses on developing a computational and genomics-based technology platform aimed at discovering and creating next-generation microbial products. The company's innovative approach leverages advanced data analysis and genomic insights to enhance the development of microbial solutions, catering to various applications in biotechnology and related fields.

ShopBack

Series B in 2020
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Fabric

Series B in 2020
Fabric operates an on-demand supply chain network platform designed to enhance retail delivery services, allowing for sustainable and rapid delivery options, including same-day and one-hour services. The company utilizes micro fulfillment centers equipped with robotics and artificial intelligence to automate various order preparation processes such as inventory reception, order picking, and packing. By positioning these local inventory hubs close to end-customers, Fabric enables retailers to improve their customer experience while maintaining profitable unit economics. Founded in 2015 and based in Tel Aviv, Israel, Fabric aims to drive revenue and customer loyalty for retailers through advanced software and automation, ultimately fostering greater operational efficiency and lower costs.

UPSIDE Foods

Series B in 2020
UPSIDE Foods, formerly known as Memphis Meats, is a cultivated meat company founded in 2015 and headquartered in Berkeley, California. The company specializes in producing real meat, poultry, and seafood directly from animal cells, eliminating the need to raise and slaughter animals. This innovative approach significantly reduces the resource consumption associated with traditional meat production, requiring less water, land, and energy. UPSIDE Foods aims to offer consumers clean, humane, and sustainable meat products, such as beef meatballs, chicken, and duck, all grown in controlled environments. The company is led by Dr. Uma Valeti, who is committed to transforming the food industry with healthier and environmentally friendly alternatives to conventional meat.

Soul Machines

Series B in 2020
Soul Machines Limited, founded in 2016 and headquartered in Auckland, New Zealand, specializes in the development of emotionally responsive avatars that enhance user experiences across various artificial intelligence platforms. The company offers a range of products, including the Digital DNA Studio, which allows users to create custom digital avatars for applications in customer care, marketing, education, and more. By utilizing its innovative Biological AI technology and patented Digital Brain™, Soul Machines aims to humanize AI, creating engaging and empathetic AI assistants that facilitate deeper interactions and personalized experiences. With additional offices in major cities worldwide, including San Francisco, New York, London, Tokyo, and Melbourne, Soul Machines is at the forefront of transforming customer engagement through ethical and responsive human-machine collaboration.

Transcenta Holding

Series B in 2020
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company focused on the research, development, and manufacturing of antibody-based therapeutics. Established in 2019 and headquartered in Suzhou, China, the company operates additional facilities in Shanghai, Hangzhou, Beijing, Waltham, and Princeton. Transcenta's integrated approach encompasses the discovery and development of innovative antibodies aimed at addressing various medical conditions, particularly in oncology and specific non-oncology areas such as bone and kidney disorders. The company is currently advancing nine therapeutic antibody molecules through clinical development, underscoring its commitment to improving patient outcomes. Transcenta was formed through the merger of HJB and MabSpace Biosciences, positioning it as a significant player in the global biopharmaceutical landscape.

Eigen Technologies

Series B in 2019
Eigen Technologies Limited specializes in intelligent document processing, developing software that utilizes machine learning to extract and analyze data from complex documents. Founded in 2014 and headquartered in London with an office in New York, Eigen helps clients in finance, law, and professional services manage risk, scale operations, and navigate regulatory environments. The platform effectively automates the extraction of answers from documents, enhancing accuracy while ensuring data security. By recognizing patterns and understanding context, Eigen's technology allows organizations to transform unstructured data into actionable insights, thereby facilitating informed decision-making. The company's client base includes prominent firms such as Goldman Sachs, ING, and BlackRock, with a significant portion of globally systemically important banks using Eigen's solutions to address their document-related challenges.

pureLiFi

Series B in 2019
pureLiFi Ltd. is a light communications technology company based in Edinburgh, United Kingdom, specializing in Li-Fi, a visible light communications technology that utilizes the visible light spectrum for wireless data transmission. Founded in 2012, pureLiFi develops various products, including the Li-1st platform for testing VLC applications and Li-Flame solutions that enhance network security by preventing external intrusions. The company also offers the Li-Fire Platform, along with ceiling and desktop units, and LiFi-XC devices that provide secure wireless communications compatible with multiple operating systems. Its innovative technology addresses the challenges of diminishing wireless capacity, serving applications across diverse sectors such as healthcare, aviation, and transportation. By converting light into electrical signals, pureLiFi enables high-density data transmission, presenting a viable alternative to traditional Wi-Fi.

Bowery Farming

Series B in 2019
Bowery Farming Inc. is a modern agricultural company based in New York, specializing in post-organic produce. Founded in 2014, the company focuses on growing a variety of greens, including baby kale, lettuce, arugula, and basil, using innovative indoor farming techniques. By leveraging advanced technology, such as its proprietary BoweryOS software, Bowery Farming creates optimal conditions for plant growth, allowing it to operate without pesticides and using significantly less water compared to traditional farming methods. This technology enables the company to be over 100 times more productive on the same land footprint. Bowery's products are distributed through grocery stores and featured in the menus of renowned restaurants, emphasizing the company's commitment to providing fresh, sustainable produce to consumers.

Viela Bio

Series B in 2019
Viela Bio, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, focused on the research and development of innovative treatments for severe inflammation and autoimmune diseases. The company's lead product candidate, inebilizumab, is a humanized monoclonal antibody targeting CD19, designed for conditions such as neuromyelitis optica spectrum disorder, kidney transplant desensitization, myasthenia gravis, and IgG4-related diseases. In addition to inebilizumab, Viela Bio is developing VIB4920, aimed at preventing kidney transplant rejection and treating Sjögren's syndrome, and VIB7734, which targets cutaneous lupus erythematosus. The company has formed a strategic partnership with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases across several countries in Asia. Founded in 2017, Viela Bio is committed to addressing critical pathways underlying autoimmune diseases to improve patient outcomes.

Gracell Biotechnologies

Series B in 2019
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing cell therapies for cancer treatment. The company’s lead product candidates include GC012F, a dual-target autologous CAR-T therapy for multiple myeloma, and GC019F, which targets adult B cell acute lymphoblastic leukemia and is also being investigated for relapsed or refractory B cell non-Hodgkin’s lymphoma. Additionally, Gracell is developing GC007F for B cell non-Hodgkin's lymphoma and GC027, an allogeneic CAR-T product candidate for adult T cell acute lymphoblastic leukemia. The company also has GC007g, a donor-derived therapy for relapsed or refractory B cell acute lymphoblastic leukemia, and a pipeline of earlier stage candidates targeting other cancer types, including ovarian cancer and breast cancer. Founded in 2017, Gracell aims to provide innovative cellular therapeutics that enhance treatment options for patients suffering from various hematological malignancies and solid tumors.

Perfect Day

Series B in 2019
Perfect Day, Inc. is a pioneering company based in Emeryville, California, that specializes in producing animal-free dairy products. Founded in 2014, the company creates milk, cheese, yogurt, milk proteins, and ice cream that are nutritionally identical to traditional dairy but are made through a fermentation process using plant-based sugars. This innovative approach allows Perfect Day to deliver products that retain the taste, texture, and nutrition of conventional dairy while eliminating concerns related to food safety, environmental impact, and animal welfare. The company's commitment to sustainability and compassion results in nutrient-dense alternatives that are vegan, free from antibiotics, cholesterol, and lactose, catering to a growing market for healthier and more ethical food options.

Bowery Farming

Series B in 2018
Bowery Farming Inc. is a modern agricultural company based in New York, specializing in post-organic produce. Founded in 2014, the company focuses on growing a variety of greens, including baby kale, lettuce, arugula, and basil, using innovative indoor farming techniques. By leveraging advanced technology, such as its proprietary BoweryOS software, Bowery Farming creates optimal conditions for plant growth, allowing it to operate without pesticides and using significantly less water compared to traditional farming methods. This technology enables the company to be over 100 times more productive on the same land footprint. Bowery's products are distributed through grocery stores and featured in the menus of renowned restaurants, emphasizing the company's commitment to providing fresh, sustainable produce to consumers.

Pivot Bio

Series B in 2018
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

BITMAIN

Series B in 2018
Bitmain is a leading manufacturer of Bitcoin mining hardware, specializing in the development and sale of miners utilizing ASIC chip technology. Founded by pioneers in the digital currency sector, the company is staffed by a team of skilled engineers, financial experts, and cryptocurrency enthusiasts. Headquartered in Beijing, Bitmain also maintains offices in cities such as San Francisco, Tel Aviv, Hong Kong, Chengdu, and Shenzhen. The company focuses on providing high-quality, efficient computing solutions, including high-density server equipment and large-scale parallel computing software, to support the cryptocurrency mining industry.

WeWork

Series B in 2018
WeWork is a global commercial real estate company that transforms buildings into collaborative workspaces, catering to a wide range of clients from freelancers to Fortune 500 companies. Founded in 2010, it provides flexible, serviced office spaces along with infrastructure, services, and technology to foster productivity and creativity. With over 20,000 members worldwide, WeWork aims to create a community where people can work to make a life, not just a living. Its revenue streams include membership fees for office space access and additional billings for ancillary services. WeWork also operates WeWork Labs, a platform supporting early-stage startups, and has a presence in China and India through its subsidiaries.

SHIELD

Series B in 2018
SHIELD specializes in online fraud management solutions that assist enterprises in mitigating the risks associated with fraudulent payments and accounts. The company employs advanced technology, including trading algorithms, real-time pattern recognition, and passive biometric analytics, to identify fraudulent behaviors autonomously. SHIELD offers a comprehensive suite of services, including fraud prevention, network security, credit intelligence, and identity verification. It serves a diverse range of industries, including mobile applications, digital wallets, e-commerce, and marketplaces. Trusted by major global enterprises such as Razer, Alibaba, and BEAT, SHIELD safeguards over seven billion devices and protects approximately 500 million user accounts annually. Founded in 2007 and based in Singapore, the company was previously known as CashRun Pte Ltd.

Claroty

Series B in 2018
Claroty Ltd. is an industrial cybersecurity company based in New York, established in 2014. It specializes in operational technology (OT) security, providing a platform that helps organizations protect and optimize their OT, IoT, and IIoT assets. Claroty's services focus on discovering critical data within industrial networks, including industrial control systems and supervisory control and data acquisition (SCADA) systems. The company's platform integrates seamlessly with existing infrastructure to deliver comprehensive cybersecurity controls, including visibility, threat detection, risk and vulnerability management, and secure remote access. This approach enables organizations to enhance the safety and reliability of their assets and networks while minimizing downtime and improving operational efficiency.

Hangzhou Just Biotherapeutics

Series B in 2018
Hangzhou Just Biotherapeutics, also known as Just China, is a biotechnology company founded in 2016 and based in Hangzhou, China. The company focuses on the development of antibody and recombinant protein bio-therapeutics, utilizing advanced molecular and process design techniques. As a subsidiary of MabSpace Biosciences Co., Ltd., Hangzhou Just Biotherapeutics aims to overcome scientific and technical challenges in the field of biologics. Their innovative technology enhances the development process for bio-medicine while significantly lowering manufacturing costs, thereby accelerating the availability of therapeutic solutions.

Helix

Series B in 2018
Helix is a prominent population genomics company that focuses on the convergence of clinical care, research, and genomics. Its comprehensive platform assists health systems, life sciences companies, and payers in advancing genomic research and integrating genomic data into clinical practice. Helix operates one of the world's largest CLIA/CAP-certified next-generation sequencing labs and utilizes its proprietary Exome+ assay to support various aspects of population genomics, including participant recruitment, disease screening, result reporting, and both basic and translational research.

Rokid Technology

Series B in 2018
Rokid Technology, established in 2014, is a California-based company specializing in artificial intelligence and robotics. It develops and manufactures smart devices, including AI-powered smart speakers and augmented reality (AR) smart glasses. Rokid's products, such as the Rokid Glass, incorporate advanced AI capabilities like facial recognition, language translation, and voice control, providing users with an interactive experience by overlaying digital information onto the physical world. The company's offerings cater to both consumer and industrial markets, aiming to enhance human-computer interaction through superior industrial design and user experience.

Pear Therapeutics

Series B in 2018
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Orchard Therapeutics

Series B in 2017
Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. The company employs an autologous ex vivo gene therapy approach, which aims to modify a patient's hematopoietic stem cells to create a personalized treatment through a single administration. Orchard's product portfolio includes Strimvelis, the first gene therapy approved by the European Medicines Agency for adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company is advancing several clinical programs, including OTL-101 for ADA-SCID, OTL-200 for metachromatic leukodystrophy, OTL-103 for Wiskott-Aldrich syndrome, OTL-102 for X-linked chronic granulomatous disease, and OTL-300 for transfusion-dependent beta-thalassemia. Additionally, Orchard has a robust preclinical pipeline targeting various mucopolysaccharidosis types. Founded in 2015, Orchard Therapeutics collaborates with leading institutions in the field to enhance its research and development efforts.

Arterys

Series B in 2017
Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Genuity Science

Series B in 2017
Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.

Hangzhou Just Biotherapeutics

Series B in 2017
Hangzhou Just Biotherapeutics, also known as Just China, is a biotechnology company founded in 2016 and based in Hangzhou, China. The company focuses on the development of antibody and recombinant protein bio-therapeutics, utilizing advanced molecular and process design techniques. As a subsidiary of MabSpace Biosciences Co., Ltd., Hangzhou Just Biotherapeutics aims to overcome scientific and technical challenges in the field of biologics. Their innovative technology enhances the development process for bio-medicine while significantly lowering manufacturing costs, thereby accelerating the availability of therapeutic solutions.

Homology Medicines

Series B in 2017
Homology Medicines, Inc., established in 2015 and headquartered in Bedford, Massachusetts, is a biotechnology company focused on developing genetic medicines for patients with rare genetic diseases. The company's proprietary platform employs human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to deliver genetic therapies or nuclease-free gene editing treatments in vivo, targeting various disease-relevant tissues such as the liver, central nervous system, and eye. Homology Medicines has two lead product candidates: HMI-102, currently in a Phase 1/2 clinical trial for treating phenylketonuria (PKU) in adults, and HMI-103, intended for PKU treatment in pediatric patients. Additionally, the company is developing HMI-202 to treat metachromatic leukodystrophy. Homology Medicines aims to cure the underlying causes of these diseases by leveraging its robust intellectual property portfolio and experienced management team with a proven track record in rare disease therapeutics.

Within (VR/AR)

Series B in 2017
Within is the premier destination for innovative, entertaining, and informative story-based virtual reality and augmented reality. We bring together the best immersive experiences from the world's finest VR/AR creators—from gripping tales set in worlds of pure imagination to documentaries taking you further inside the news than ever before. Within supports all major headsets, including Oculus Quest, Rift, HTC Vive, Sony PlayStation VR, and Samsung Gear VR. To get started experiencing our ever-growing roster of content, just download our app for iPhone or Android today.

Genuity Science

Series B in 2017
Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.

IguanaFix

Series B in 2016
IguanaFix operates an online marketplace that facilitates repair and maintenance services for residential and commercial properties. The platform allows users to post various tasks, such as plumbing, electrical work, and painting, while connecting them with qualified service providers. By conducting identity checks and scheduling on-demand visits, IguanaFix ensures a reliable experience for its customers. Users can compare prices and make payments at predetermined market rates, streamlining the process of finding and hiring technicians. To date, over 40,000 technicians have utilized the platform to complete more than one million jobs, reflecting its effectiveness in simplifying maintenance and field operations management.

Nio

Series B in 2016
Nio is a Chinese electric vehicle manufacturer that designs, manufactures, and sells premium smart electric vehicles globally. Founded in 2014, Nio offers a range of SUVs with varying seating capacities, along with innovative charging solutions such as battery swapping services and mobile charging trucks. The company also provides value-added services like insurance packages, maintenance, and roadside assistance. Nio collaborates with industry leaders for autonomous driving technologies and manufactures its vehicles through strategic partnerships. As of 2023, Nio has sold over 160,000 electric vehicles in China alone, capturing approximately 2% of the market share for new energy passenger vehicles.

pureLiFi

Series B in 2016
pureLiFi Ltd. is a light communications technology company based in Edinburgh, United Kingdom, specializing in Li-Fi, a visible light communications technology that utilizes the visible light spectrum for wireless data transmission. Founded in 2012, pureLiFi develops various products, including the Li-1st platform for testing VLC applications and Li-Flame solutions that enhance network security by preventing external intrusions. The company also offers the Li-Fire Platform, along with ceiling and desktop units, and LiFi-XC devices that provide secure wireless communications compatible with multiple operating systems. Its innovative technology addresses the challenges of diminishing wireless capacity, serving applications across diverse sectors such as healthcare, aviation, and transportation. By converting light into electrical signals, pureLiFi enables high-density data transmission, presenting a viable alternative to traditional Wi-Fi.

Modern Meadow

Series B in 2016
Modern Meadow, LLC is a biofabrication company based in Brooklyn, New York, founded in 2011. The company specializes in creating animal-free leather from living cells, utilizing its proprietary Bio-Alloy and Bio-Farm technology platforms. These innovations leverage tuned proteins to produce sustainable materials that eliminate the need for petrochemical and animal-derived inputs while maintaining high performance. Modern Meadow’s products are designed for seamless integration into existing infrastructures across various industries, including materials and beauty. The company emphasizes lab-to-brand traceability, ensuring that its offerings are fully transparent throughout the production process. By focusing on fermentation-based bio-collagen and lightweight materials, Modern Meadow aims to significantly reduce greenhouse gas emissions and promote sustainability without compromising quality or appearance.

AccuraGen

Series B in 2016
AccuraGen Inc., founded in 2013 and located in Menlo Park, California, specializes in developing sequencing-based systems for detecting cancer mutations. The company has created a high-sensitivity technology that utilizes next-generation sequencing to identify cancer-related mutations in small amounts of circulating cell-free DNA (cfDNA) found in blood samples. This innovative approach addresses challenges in analyzing cfDNA by employing proprietary molecular biology techniques and computational algorithms that enhance error suppression. AccuraGen's system can amplify nanogram quantities of highly fragmented cfDNA over 1000-fold, allowing for the screening of a wide array of cancer-related genes with exceptional sensitivity, including at the single-digit molecular level. This technology aims to improve personalized cancer treatment by providing oncologists and clinicians with reliable molecular diagnostic capabilities.

Team8

Series B in 2016
Team8 is a global venture group established in 2014, headquartered in Tel Aviv, Israel. It specializes in building and investing in companies focused on enterprise technology, cybersecurity, data science, AI, and fintech. Team8's unique "Foundry" model involves identifying significant challenges, brainstorming innovative solutions, and supporting startups to ensure their success. The company leverages an in-house, multidisciplinary team and a dedicated network of C-level executives and thought leaders. Team8's leadership comprises serial entrepreneurs and industry pioneers, including former members of Israel's elite tech and intelligence Unit 8200. Backed by global corporations such as Microsoft, Walmart, Cisco, Barclays, and Moody's, Team8 co-founds transformative fintech companies, enhances established fintech value propositions, and empowers non-financial companies to offer financial services. Additionally, Team8 invests in early-stage enterprise technology startups through its venture capital fund, Team8 Capital I, focusing on data, AI, cybersecurity, and fintech sectors.

HELIX

Series B in 2015
HELIX, originally known as Flux and the first spin-out from Google X, is based in Oakland, California. The company initially focused on generative building design but shifted in 2019 to address the challenges of digitizing buildings. HELIX developed the HELIX Creator platform, which allows architects, engineers, builders, and owner-operators to utilize LiDAR and photogrammetry for capturing precise building geometry, transforming it into practical plans and models. This platform provides users with timely access to accurate 2D and 3D information, as well as essential documents and data related to buildings. HELIX's technology is instrumental in assessing building potential, planning renovations, and detailed documentation for disaster preparedness. The company emphasizes the importance of accurate and easily accessible data to fully realize the capabilities of Digital Twins.

Jet

Series B in 2015
Jet is an e-commerce shopping platform that enables users to shop online from a diverse array of retailers. Founded in April 2014 by Mark Lore, Mike Hanrahan, and Nate Faust, the company is headquartered in Hoboken, New Jersey. Jet offers a wide selection of products across various categories, including household goods, health and beauty, groceries, electronics, clothing, and more. The platform is designed to provide a user-friendly shopping experience, allowing customers to purchase items conveniently, including options for cash on delivery. Since September 2016, Jet has operated as a subsidiary of Wal-Mart Stores, enhancing its reach within the competitive online retail market.

Adyen

Series B in 2014
Adyen is a global financial technology platform that specializes in providing integrated payment solutions for businesses. The company enables merchants to accept e-commerce, mobile, and point-of-sale payments across multiple countries, utilizing a variety of payment methods. Initially focused on gateway and payment processing services, Adyen expanded its offerings to include merchant acquiring services, reflecting its commitment to comprehensive payment solutions. The company holds a banking license to enhance the settlement processes for merchant accounts. With a presence in numerous markets, Adyen serves a diverse range of clients, including prominent companies such as Facebook, Uber, H&M, eBay, and Microsoft, empowering them to achieve their financial goals efficiently.

Visterra

Series B in 2014
Visterra, Inc. is a clinical-stage biopharmaceutical company focused on developing precision antibody-based treatments for difficult-to-treat diseases, particularly infectious diseases. Utilizing its Hierotope platform, Visterra designs monoclonal antibodies such as VIS410, aimed at treating hospitalized patients with influenza A, and VIS513 for Dengue fever. The company is also advancing VIS705, an antibody-drug conjugate for Pseudomonas aeruginosa infections, and VIS649, which targets Immunoglobulin A Nephropathy (IgAN). Founded in 2007 and based in Waltham, Massachusetts, Visterra was previously known as Parasol Therapeutics, Inc. The company operates as a subsidiary of Otsuka America, Inc. and emphasizes innovative therapeutic solutions to address significant unmet medical needs.

Krux

Series B in 2014
Krux Digital Inc. develops a cloud-based data management platform designed for marketers, media companies, publishers, and agencies on a global scale. The platform consolidates consumer data from various sources and devices, analyzes individual preferences, and activates this data in real time across multiple channels, including desktop, mobile, social, and video. Founded in 2010 and headquartered in San Francisco, Krux operates additional offices in major cities worldwide. The company provides a comprehensive range of services, including audience data management, identity management, and cross-channel frequency management. With its platform, Krux enables businesses to deliver tailored content, advertising, and shopping experiences, making it easier to engage audiences effectively. As of November 2016, Krux operates as a subsidiary of Salesforce.com.

iTutorGroup

Series B in 2014
iTutorGroup is an online education provider founded in 1998, headquartered in Taipei City, Taiwan, with additional offices in Shanghai, China, and Santa Clara, California. The company offers a range of platforms designed for both students and business professionals, including VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English language learning, as well as TutorMing for Mandarin Chinese language instruction. Additionally, iTutorGroup provides LiveH2H, a service for live translations in multiple languages. The company focuses on delivering individualized and personalized learning experiences, allowing instructors to tailor content to meet the specific needs of learners.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.